Study of Prasugrel in Children who have Sickle Cell Disease

Update Il y a 4 ans
Reference: EUCTR2017-001243-12

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Pharmacokinetics: Area Under the Concentration-Time Curve (AUC) of Prasugrel Active Metabolite (Pras-AM) [ Time Frame: Parts A and B: 0.5, 1, 1.5, 2, 4 hours postdose ] •Percentage of Platelet Inhibition as Measured by VerifyNow™P2Y12 (VN) [ Time Frame: Part A: 4 hours postdose and Part B: at steady state (14 ± 4 days after the start of each new dosage) ]


Inclusion criteria

  • Sickle Cell Disease

Links